• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effects of baseline depression severity on remission rates with duloxetine and placebo in anxious and nonanxious patients with major depression.

作者信息

Nelson J Craig

出版信息

J Clin Psychopharmacol. 2011 Oct;31(5):682-4. doi: 10.1097/JCP.0b013e31822bee26.

DOI:10.1097/JCP.0b013e31822bee26
PMID:21881463
Abstract
摘要

相似文献

1
Effects of baseline depression severity on remission rates with duloxetine and placebo in anxious and nonanxious patients with major depression.
J Clin Psychopharmacol. 2011 Oct;31(5):682-4. doi: 10.1097/JCP.0b013e31822bee26.
2
Anxiety does not predict response to duloxetine in major depression: results of a pooled analysis of individual patient data from 11 placebo-controlled trials.焦虑并不能预测度洛西汀治疗重度抑郁症的疗效：来自 11 项安慰剂对照试验的个体患者数据汇总分析的结果。
Depress Anxiety. 2010;27(1):12-8. doi: 10.1002/da.20632.
3
Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.度洛西汀治疗的轻度、中度或更严重抑郁症门诊患者的抑郁症状反应模式。
Int J Clin Pract. 2007 Aug;61(8):1337-48. doi: 10.1111/j.1742-1241.2007.01444.x.
4
Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.使用 Sheehan 残疾量表的 discan 度量评估重度抑郁症和广泛性焦虑症临床试验中的缓解情况。
Int Clin Psychopharmacol. 2011 Mar;26(2):75-83. doi: 10.1097/YIC.0b013e328341bb5f.
5
Time course of improvement of different symptom clusters in patients with major depression and pain treated with duloxetine or placebo.度洛西汀与安慰剂治疗伴疼痛的重性抑郁患者不同症状群改善的时间进程。
Curr Med Res Opin. 2012 Jan;28(1):41-8. doi: 10.1185/03007995.2011.645561. Epub 2011 Dec 22.
6
Predictors of remission with placebo using an integrated study database from patients with major depressive disorder.使用重性抑郁障碍患者的综合研究数据库预测安慰剂缓解率的预测因素。
Curr Med Res Opin. 2012 Mar;28(3):325-34. doi: 10.1185/03007995.2011.654010. Epub 2012 Jan 31.
7
Duloxetine 60 mg once daily in the treatment of milder major depressive disorder.度洛西汀每日一次60毫克用于治疗较轻的重度抑郁症。
Int J Clin Pract. 2006 May;60(5):613-20. doi: 10.1111/j.1368-5031.2006.00956.x.
8
A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.度洛西汀与文拉法辛治疗重度抑郁症患者的随机双盲对照研究
J Psychiatr Res. 2008 Jan;42(1):22-34. doi: 10.1016/j.jpsychires.2007.01.008. Epub 2007 Apr 18.
9
Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.度洛西汀治疗重度抑郁症：有与无 melancholic 特征患者的疗效比较
BMC Psychiatry. 2005 Jan 4;5:1. doi: 10.1186/1471-244X-5-1.
10
Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.文拉法辛和氟西汀治疗重度抑郁症实现缓解：其与焦虑症状的关系。
Depress Anxiety. 2002;16(1):4-13. doi: 10.1002/da.10045.

引用本文的文献

1
Pharmacologic treatment of dimensional anxious depression: a review.维度性焦虑抑郁的药物治疗：综述
Prim Care Companion CNS Disord. 2014;16(3). doi: 10.4088/PCC.13r01621. Epub 2014 May 29.